![Janice McCourt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janice Marie McCourt is currently the Chief Executive Officer at Hudson Therapeutics, Inc. and the Chief Business Officer at Comera Life Sciences Holdings, Inc. Her former positions include Vice President-Business Development at Agenus, Inc., Scorpius Holdings, Inc., and Chief Business & Corporate Development Officer at Lyvgen Biopharma Holdings Ltd. She completed her undergraduate degree at Massachusetts College of Pharmacy & Health Science and holds an MBA from the University of Phoenix.
| Unternehmen | Position | Beginn |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 09.11.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Corporate Officer/Principal | 01.01.2019 |
Lyvgen Biopharma Holdings Ltd | Corporate Officer/Principal | - |
| AGENUS INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Lyvgen Biopharma Holdings Ltd |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
